Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Parkinson's Disease

  Free Subscription


Articles published in Neurobiol Dis

Retrieve available abstracts of 53 articles:
HTML format
Text format



Single Articles


    December 2018
  1. MUS L, Siani F, Giuliano C, Ghezzi C, et al
    Development and biochemical characterization of a mouse model of Parkinson's disease bearing defective glucocerebrosidase activity.
    Neurobiol Dis. 2018 Dec 3. pii: S0969-9961(18)30756.
    PubMed     Text format     Abstract available


    November 2018
  2. HUANG YR, Xie XX, Ji M, Yu XL, et al
    Naturally occurring autoantibodies against alpha-synuclein rescues memory and motor deficits and attenuates alpha-synuclein pathology in mouse model of Parkinson's disease.
    Neurobiol Dis. 2018 Nov 24. pii: S0969-9961(18)30401.
    PubMed     Text format     Abstract available


  3. CHO SS, Christopher L, Koshimori Y, Li C, et al
    Decreased pallidal vesicular monoamine transporter type 2 availability in Parkinson's disease: The contribution of the nigropallidal pathway.
    Neurobiol Dis. 2018;124:176-182.
    PubMed     Text format     Abstract available


  4. REED X, Bandres-Ciga S, Blauwendraat C, Cookson MR, et al
    The role of monogenic genes in idiopathic Parkinson's disease.
    Neurobiol Dis. 2018 Nov 15. pii: S0969-9961(18)30668.
    PubMed     Text format     Abstract available


  5. IKEDA-MATSUO Y, Miyata H, Mizoguchi T, Ohama E, et al
    Microsomal prostaglandin E synthase-1 is a critical factor in dopaminergic neurodegeneration in Parkinson's disease.
    Neurobiol Dis. 2018 Nov 10. pii: S0969-9961(18)30741.
    PubMed     Text format     Abstract available


  6. SAMPEDRO F, Marin-Lahoz J, Martinez-Horta S, Pagonabarraga J, et al
    Dopaminergic degeneration induces early posterior cortical thinning in Parkinson's disease.
    Neurobiol Dis. 2018 Nov 5. pii: S0969-9961(18)30544.
    PubMed     Text format     Abstract available


  7. LAMONTAGNE-PROULX J, St-Amour I, Labib R, Pilon J, et al
    Portrait of blood-derived extracellular vesicles in patients with Parkinson's disease.
    Neurobiol Dis. 2018 Nov 5. pii: S0969-9961(18)30534.
    PubMed     Text format     Abstract available


  8. MILOSEVIC L, Gramer R, Kim TH, Algarni M, et al
    Modulation of inhibitory plasticity in basal ganglia output nuclei of patients with Parkinson's disease.
    Neurobiol Dis. 2018 Nov 1. pii: S0969-9961(18)30593.
    PubMed     Text format     Abstract available


    October 2018
  9. WEIHOFEN A, Liu Y, Arndt JW, Huy C, et al
    Development of an aggregate-selective, human-derived alpha-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease models.
    Neurobiol Dis. 2018 Oct 28. pii: S0969-9961(18)30448.
    PubMed     Text format     Abstract available


  10. HERNANDO S, Requejo C, Herran E, Ruiz-Ortega JA, et al
    Beneficial effects of n-3 polyunsaturated fatty acids administration in a partial lesion model of Parkinson's disease: The role of glia and NRf2 regulation.
    Neurobiol Dis. 2018 Oct 5. pii: S0969-9961(18)30292.
    PubMed     Text format     Abstract available


    September 2018
  11. SOYAL SM, Zara G, Ferger B, Felder TK, et al
    The PPARGC1A locus and CNS-specific PGC-1alpha isoforms are associated with Parkinson's Disease.
    Neurobiol Dis. 2018 Sep 17. pii: S0969-9961(18)30591.
    PubMed     Text format     Abstract available


  12. PINA-FUENTES D, van Zijl JC, van Dijk JMC, Little S, et al
    The characteristics of pallidal low-frequency and beta bursts could help implementing adaptive brain stimulation in the parkinsonian and dystonic internal globus pallidus.
    Neurobiol Dis. 2018 Sep 15. pii: S0969-9961(18)30391.
    PubMed     Text format     Abstract available


  13. MAMMADOVA N, Summers CM, Kokemuller RD, He Q, et al
    Accelerated accumulation of retinal alpha-synuclein (pSer129) and tau, neuroinflammation and autophagic dysregulation in a seeded mouse model of Parkinson's disease.
    Neurobiol Dis. 2018 Sep 12. pii: S0969-9961(18)30204.
    PubMed     Text format     Abstract available


  14. ANIDI CM, O'Day JJ, Anderson RW, Afzal MF, et al
    Neuromodulation targets pathological not physiological beta bursts during gait in Parkinson's disease.
    Neurobiol Dis. 2018 Sep 6. pii: S0969-9961(18)30548.
    PubMed     Text format     Abstract available


    August 2018
  15. TUBERT C, Galtieri D, James Surmeier D
    The pedunclopontine nucleus and Parkinson's disease.
    Neurobiol Dis. 2018 Aug 29. pii: S0969-9961(18)30493.
    PubMed     Text format     Abstract available


  16. MOLONEY EB, Moskites A, Ferrari EJ, Isacson O, et al
    The glycoprotein GPNMB is selectively elevated in the substantia nigra of Parkinson's disease patients and increases after lysosomal stress.
    Neurobiol Dis. 2018 Aug 24. pii: S0969-9961(18)30484.
    PubMed     Text format     Abstract available


  17. GOETZ L, Piallat B, Bhattacharjee M, Mathieu H, et al
    Spike discharge characteristic of the caudal mesencephalic reticular formation and pedunculopontine nucleus in MPTP-induced primate model of Parkinson disease.
    Neurobiol Dis. 2018 Aug 4. pii: S0969-9961(18)30394.
    PubMed     Text format     Abstract available


    June 2018
  18. THEVATHASAN W, Moro E
    What is the therapeutic mechanism of pedunculopontine nucleus stimulation in Parkinson's disease?
    Neurobiol Dis. 2018 Jun 19. pii: S0969-9961(18)30193.
    PubMed     Text format     Abstract available


  19. TINKHAUSER G, Torrecillos F, Duclos Y, Tan H, et al
    Beta burst coupling across the motor circuit in Parkinson's disease.
    Neurobiol Dis. 2018 Jun 14. pii: S0969-9961(18)30182.
    PubMed     Text format     Abstract available


  20. TOZZI A, Durante V, Bastioli G, Mazzocchetti P, et al
    Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease.
    Neurobiol Dis. 2018 Jun 13. pii: S0969-9961(18)30185.
    PubMed     Text format     Abstract available


    May 2018
  21. POLAR CA, Gupta R, Lehmkuhle MJ, Dorval AD, et al
    Correlation between cortical beta power and gait speed is suppressed in a parkinsonian model, but restored by therapeutic deep brain stimulation.
    Neurobiol Dis. 2018 May 30. pii: S0969-9961(18)30151.
    PubMed     Text format     Abstract available


    April 2018
  22. PAN PY, Zhu Y, Shen Y, Yue Z, et al
    Crosstalk between presynaptic trafficking and autophagy in Parkinson's disease.
    Neurobiol Dis. 2018 Apr 30. pii: S0969-9961(18)30136.
    PubMed     Text format     Abstract available


  23. WANG H, Atik A, Stewart T, Ginghina C, et al
    Plasma alpha-synuclein and cognitive impairment in the Parkinson's Associated Risk Syndrome: A pilot study.
    Neurobiol Dis. 2018 Apr 26. pii: S0969-9961(18)30123.
    PubMed     Text format     Abstract available


  24. ANDERSEN MA, Christensen KV, Badolo L, Smith GP, et al
    Parkinson's disease-like burst firing activity in subthalamic nucleus induced by AAV-alpha-synuclein is normalized by LRRK2 modulation.
    Neurobiol Dis. 2018 Apr 19. pii: S0969-9961(18)30119.
    PubMed     Text format     Abstract available


  25. DE MIRANDA BR, Rocha EM, Bai Q, El Ayadi A, et al
    Astrocyte-specific DJ-1 overexpression protects against rotenone-induced neurotoxicity in a rat model of Parkinson's disease.
    Neurobiol Dis. 2018 Apr 9. pii: S0969-9961(18)30116.
    PubMed     Text format     Abstract available


    March 2018
  26. GLEAVE JA, Arathoon LR, Trinh D, Lizal KE, et al
    Corrigendum to "Sirtuin 3 rescues neurons through the stabilisation of mitochondrial biogenetics in the virally-expressing mutant alpha-synuclein rat model of parkinsonism" [Neurobiol. Dis. 106 (2018) 133-146].
    Neurobiol Dis. 2018 Mar 20. pii: S0969-9961(18)30054.
    PubMed     Text format    


  27. PITCAIRN C, Wani WY, Mazzulli JR
    Dysregulation of the autophagic-lysosomal pathway in Gaucher and Parkinson's disease.
    Neurobiol Dis. 2018 Mar 14. pii: S0969-9961(18)30074.
    PubMed     Text format     Abstract available


  28. PUSKA G, Lutz MI, Molnar K, Regelsberger G, et al
    Lysosomal response in relation to alpha-synuclein pathology differs between Parkinson's disease and multiple system atrophy.
    Neurobiol Dis. 2018 Mar 2. pii: S0969-9961(18)30061.
    PubMed     Text format     Abstract available


    February 2018
  29. RIZZI N, Brunialti E, Cerri S, Cermisoni G, et al
    In vivo imaging of early signs of dopaminergic neuronal death in an animal model of Parkinson's disease.
    Neurobiol Dis. 2018 Feb 24. pii: S0969-9961(18)30037.
    PubMed     Text format     Abstract available


  30. PIERCE SE, Tyson T, Booms A, Prahl J, et al
    Parkinson's disease genetic risk in a midbrain neuronal cell line.
    Neurobiol Dis. 2018 Feb 24. pii: S0969-9961(18)30039.
    PubMed     Text format     Abstract available


  31. WU HM, Li T, Wang ZF, Huang SS, et al
    Mitochondrial DNA variants modulate genetic susceptibility to Parkinson's disease in Han Chinese.
    Neurobiol Dis. 2018 Feb 24. pii: S0969-9961(18)30047.
    PubMed     Text format     Abstract available


    January 2018
  32. ALCALAY RN, Wolf P, Levy OA, Kang UJ, et al
    Alpha galactosidase A activity in Parkinson's disease.
    Neurobiol Dis. 2018 Jan 21. pii: S0969-9961(18)30018.
    PubMed     Text format     Abstract available


  33. MERCADO G, Castillo V, Soto P, Lopez N, et al
    Targeting PERK signaling with the small molecule GSK2606414 prevents neurodegeneration in a model of Parkinson's disease.
    Neurobiol Dis. 2018 Jan 17. pii: S0969-9961(18)30004.
    PubMed     Text format     Abstract available


  34. SHAROTT A, Gulberti A, Hamel W, Koppen JA, et al
    Spatio-temporal dynamics of cortical drive to human subthalamic nucleus neurons in Parkinson's disease.
    Neurobiol Dis. 2018 Jan 4. pii: S0969-9961(18)30001.
    PubMed     Text format     Abstract available


  35. ALDRIN-KIRK P, Heuer A, Rylander Ottosson D, Davidsson M, et al
    Chemogenetic modulation of cholinergic interneurons reveals their regulating role on the direct and indirect output pathways from the striatum.
    Neurobiol Dis. 2018;109.
    PubMed     Text format     Abstract available


    December 2017
  36. NELSON MP, Boutin M, Tse TE, Lu H, et al
    The lysosomal enzyme alpha-Galactosidase A is deficient in Parkinson's disease brain in association with the pathologic accumulation of alpha-synuclein.
    Neurobiol Dis. 2017;110:68-81.
    PubMed     Text format     Abstract available


    October 2017
  37. SPIGOLON G, Cavaccini A, Trusel M, Tonini R, et al
    cJun N-terminal kinase (JNK) mediates cortico-striatal signaling in a model of Parkinson's disease.
    Neurobiol Dis. 2017 Oct 28. pii: S0969-9961(17)30243.
    PubMed     Text format     Abstract available


    September 2017
  38. SYRKIN-NIKOLAU J, Koop MM, Prieto T, Anidi C, et al
    Subthalamic neural entropy is a feature of freezing of gait in freely moving people with Parkinson's disease.
    Neurobiol Dis. 2017 Sep 7. pii: S0969-9961(17)30214.
    PubMed     Text format     Abstract available


    August 2017
  39. BIOSA A, Sandrelli F, Beltramini M, Greggio E, et al
    Recent findings on the physiological function of DJ-1: Beyond Parkinson's disease.
    Neurobiol Dis. 2017 Aug 17. pii: S0969-9961(17)30186.
    PubMed     Text format     Abstract available


    July 2017
  40. RYDBIRK R, Elfving B, Andersen MD, Langbol MA, et al
    Cytokine profiling in the prefrontal cortex of Parkinson's Disease and Multiple System Atrophy patients.
    Neurobiol Dis. 2017;106:269-278.
    PubMed     Text format     Abstract available


    June 2017
  41. ARATHOON LR, Gleave JA, Trinh D, Lizal KE, et al
    Sirtuin 3 rescues neurons through the stabilisation of mitochondrial biogenetics in the virally-expressing mutant alpha-synuclein rat model of parkinsonism.
    Neurobiol Dis. 2017 Jun 30. pii: S0969-9961(17)30136.
    PubMed     Text format     Abstract available


    May 2017
  42. GIESERT F, Glasl L, Zimprich A, Ernst L, et al
    The pathogenic LRRK2 R1441C mutation induces specific deficits modeling the prodromal phase of Parkinson's disease in the mouse.
    Neurobiol Dis. 2017 May 30. pii: S0969-9961(17)30123.
    PubMed     Text format     Abstract available


    April 2017
  43. JULIENNE H, Buhl E, Leslie DS, Hodge JJL, et al
    Drosophila PINK1 and parkin loss-of-function mutants display a range of non-motor Parkinson's disease phenotypes.
    Neurobiol Dis. 2017 Apr 20. pii: S0969-9961(17)30088.
    PubMed     Text format     Abstract available


  44. CAVALIERE F, Cerf L, Dehay B, Ramos-Gonzalez P, et al
    In vitro alpha-synuclein neurotoxicity and spreading among neurons and astrocytes using Lewy body extracts from Parkinson disease brains.
    Neurobiol Dis. 2017;103:101-112.
    PubMed     Text format     Abstract available


  45. ROCHA EM, De Miranda B, Sanders LH
    Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease.
    Neurobiol Dis. 2017 Apr 8. pii: S0969-9961(17)30080.
    PubMed     Text format     Abstract available


    March 2017
  46. LALOUX C, Gouel F, Lachaud C, Timmerman K, et al
    Continuous cerebroventricular administration of dopamine: A new treatment for severe dyskinesia in Parkinson's disease?
    Neurobiol Dis. 2017 Mar 28. pii: S0969-9961(17)30061.
    PubMed     Text format     Abstract available


    December 2016
  47. SONG L, McMackin M, Nguyen A, Cortopassi G, et al
    Parkin deficiency accelerates consequences of mitochondrial DNA deletions and Parkinsonism.
    Neurobiol Dis. 2016 Dec 29. pii: S0969-9961(16)30314.
    PubMed     Text format     Abstract available


  48. MASILAMONI GJ, Groover O, Smith Y
    Reduced noradrenergic innervation of ventral midbrain dopaminergic cell groups and the subthalamic nucleus in MPTP-treated parkinsonian monkeys.
    Neurobiol Dis. 2016 Dec 29. pii: S0969-9961(16)30315.
    PubMed     Text format     Abstract available


  49. VAINE CA, Shin D, Liu C, Hendriks W, et al
    X-linked Dystonia-Parkinsonism patient cells exhibit altered signaling via nuclear factor-kappa B.
    Neurobiol Dis. 2016 Dec 22. pii: S0969-9961(16)30299.
    PubMed     Text format     Abstract available


  50. GENG X, Zhang J, Jiang Y, Ashkan K, et al
    Comparison of oscillatory activity in subthalamic nucleus in Parkinson's disease and dystonia.
    Neurobiol Dis. 2016;98:100-107.
    PubMed     Text format     Abstract available


  51. KOZINA EA, Kim AR, Kurina AY, Ugrumov MV, et al
    Cooperative synthesis of dopamine by non-dopaminergic neurons as a compensatory mechanism in the striatum of mice with MPTP-induced Parkinsonism.
    Neurobiol Dis. 2016;98:108-121.
    PubMed     Text format     Abstract available


    September 2016
  52. NKILIZA A, Mutez E, Simonin C, Lepretre F, et al
    RNA-binding disturbances as a continuum from spinocerebellar ataxia type 2 to Parkinson disease.
    Neurobiol Dis. 2016 Sep 20. pii: S0969-9961(16)30230.
    PubMed     Text format     Abstract available


  53. KIRIK D, Cederfjall E, Halliday G, Petersen A, et al
    Gene therapy for Parkinson's disease: Disease modification by GDNF family of ligands.
    Neurobiol Dis. 2016 Sep 8. pii: S0969-9961(16)30222.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: